Falcon Therapeutics
Chapel Hill, US · Founded 2015 · North Carolina corporation
Find your way into Falcon Therapeutics
Sign up to see every warm intro you have to Falcon Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Falcon Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MG
Matthew G. EwendNamed on SEC filing
AM
Anna M. SealNamed on SEC filing
SD
Shawn D. HingtgenNamed on SEC filing
KJ
Karen J. GirouxNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2017
▶$700KraisedJun 2017 · 2 investors · BiotechnologyRule 506(b)
▶$700KraisedJun 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew G. EwendDirector
- Anna M. SealExecutive Officer, Director
- Shawn D. HingtgenDirector
- Karen J. GirouxExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $700K
- First sale
- Jun 2017
- Incorporated
- Corporation, North Carolina, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Falcon Therapeutics raised?
- Falcon Therapeutics has disclosed $700K raised across 1 round.
- Where is Falcon Therapeutics headquartered?
- Falcon Therapeutics is headquartered in Chapel Hill, US.